We randomly assigned patients to receive posaconazole at a dose of 400 mg twice daily ( high-dose posaconazole ) , posaconazole at a dose of 100 mg twice daily ( low-dose posaconazole ) , or benznidazole at a dose of 150 mg twice daily ; all the study drugs were administered for 60 days .